Rockwell Medical, Inc.
RMTI
$1.47
$0.2318.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 87.97M | 97.73M | 101.49M | 98.92M | 94.37M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 87.97M | 97.73M | 101.49M | 98.92M | 94.37M |
| Cost of Revenue | 72.55M | 80.27M | 84.01M | 82.19M | 81.69M |
| Gross Profit | 15.42M | 17.46M | 17.48M | 16.72M | 12.69M |
| SG&A Expenses | 16.71M | 16.89M | 16.86M | 15.96M | 15.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 89.26M | 97.16M | 100.88M | 98.34M | 97.47M |
| Operating Income | -1.29M | 572.00K | 608.00K | 580.00K | -3.09M |
| Income Before Tax | -2.10M | -264.00K | -480.00K | -1.24M | -4.77M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.10 | -0.26 | -0.48 | -1.24 | -4.77 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.10M | -264.00K | -480.00K | -1.24M | -4.77M |
| EBIT | -1.29M | 572.00K | 608.00K | 580.00K | -3.09M |
| EBITDA | 896.00K | 2.75M | 2.79M | 2.77M | -885.00K |
| EPS Basic | -0.08 | -0.02 | -0.04 | -0.06 | -0.18 |
| Normalized Basic EPS | -0.04 | 0.00 | -0.01 | -0.03 | -0.11 |
| EPS Diluted | -0.09 | -0.03 | -0.04 | -0.07 | -0.18 |
| Normalized Diluted EPS | -0.04 | -0.01 | -0.01 | -0.03 | -0.11 |
| Average Basic Shares Outstanding | 132.85M | 128.99M | 124.21M | 119.98M | 115.95M |
| Average Diluted Shares Outstanding | 133.72M | 131.44M | 126.66M | 122.43M | 117.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |